Titre : Fécondostimulants

Fécondostimulants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neoplasm Recurrence, Local
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fécondostimulants : Questions médicales les plus fréquentes", "headline": "Fécondostimulants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fécondostimulants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-30", "dateModified": "2025-02-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fécondostimulants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Agents régulateurs de la reproduction", "url": "https://questionsmedicales.fr/mesh/D012102", "about": { "@type": "MedicalCondition", "name": "Agents régulateurs de la reproduction", "code": { "@type": "MedicalCode", "code": "D012102", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.705" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Fécondostimulants féminins", "alternateName": "Fertility Agents, Female", "url": "https://questionsmedicales.fr/mesh/D005300", "about": { "@type": "MedicalCondition", "name": "Fécondostimulants féminins", "code": { "@type": "MedicalCode", "code": "D005300", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.705.552.344" } } }, { "@type": "MedicalWebPage", "name": "Fécondostimulants masculins", "alternateName": "Fertility Agents, Male", "url": "https://questionsmedicales.fr/mesh/D005303", "about": { "@type": "MedicalCondition", "name": "Fécondostimulants masculins", "code": { "@type": "MedicalCode", "code": "D005303", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.705.552.510" } } } ], "about": { "@type": "MedicalCondition", "name": "Fécondostimulants", "alternateName": "Fertility Agents", "code": { "@type": "MedicalCode", "code": "D005299", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "N Chabbert-Buffet", "url": "https://questionsmedicales.fr/author/N%20Chabbert-Buffet", "affiliation": { "@type": "Organization", "name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France. Electronic address: nathalie.chabbert-buffet@aphp.fr." } }, { "@type": "Person", "name": "N Sermondade", "url": "https://questionsmedicales.fr/author/N%20Sermondade", "affiliation": { "@type": "Organization", "name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France." } }, { "@type": "Person", "name": "E Moreau", "url": "https://questionsmedicales.fr/author/E%20Moreau", "affiliation": { "@type": "Organization", "name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France." } }, { "@type": "Person", "name": "S Cristofari", "url": "https://questionsmedicales.fr/author/S%20Cristofari", "affiliation": { "@type": "Organization", "name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France." } }, { "@type": "Person", "name": "N Johnson", "url": "https://questionsmedicales.fr/author/N%20Johnson", "affiliation": { "@type": "Organization", "name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37182669", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jvir.2023.05.012" } }, { "@type": "ScholarlyArticle", "name": "Utility of vaginal vault cytology in the local recurrence of cervical cancer.", "datePublished": "2023-04-20", "url": "https://questionsmedicales.fr/article/37081439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12905-023-02371-7" } }, { "@type": "ScholarlyArticle", "name": "Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36649177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DCR.0000000000002551" } }, { "@type": "ScholarlyArticle", "name": "Symptoms and diagnosis of local recurrence after rectal cancer treatment.", "datePublished": "2022-08-13", "url": "https://questionsmedicales.fr/article/35968829", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/0284186X.2022.2106794" } }, { "@type": "ScholarlyArticle", "name": "Clinicopathological Characteristics of Anastomotic Recurrence After Curative Resection for Colorectal Cancer: Comparison With Nonanastomotic Local Recurrences.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36649156", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DCR.0000000000002566" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents régulateurs de la reproduction", "item": "https://questionsmedicales.fr/mesh/D012102" }, { "@type": "ListItem", "position": 6, "name": "Fécondostimulants", "item": "https://questionsmedicales.fr/mesh/D005299" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fécondostimulants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fécondostimulants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fécondostimulants", "description": "Comment diagnostiquer l'infertilité ?\nQuels tests pour évaluer la réserve ovarienne ?\nQuand consulter un spécialiste de la fertilité ?\nQuels signes indiquent un problème d'ovulation ?\nComment évaluer la qualité du sperme ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fécondostimulants", "description": "Quels symptômes d'infertilité chez la femme ?\nQuels signes d'infertilité chez l'homme ?\nComment reconnaître un déséquilibre hormonal ?\nQuels symptômes d'ovulation irrégulière ?\nQuels symptômes d'une maladie des ovaires ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fécondostimulants", "description": "Comment prévenir l'infertilité ?\nQuel rôle de l'alimentation sur la fertilité ?\nComment le stress affecte-t-il la fertilité ?\nPourquoi éviter les toxines environnementales ?\nQuel impact de l'âge sur la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fécondostimulants", "description": "Quels sont les principaux fécondostimulants ?\nComment fonctionne le clomifène ?\nQuand utiliser des gonadotrophines ?\nQuels effets secondaires des fécondostimulants ?\nComment se déroule une stimulation ovarienne ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fécondostimulants", "description": "Quelles complications des fécondostimulants ?\nComment reconnaître le syndrome d'hyperstimulation ?\nQuels risques de grossesses multiples ?\nQuelles sont les conséquences d'une grossesse multiple ?\nQuels effets à long terme des fécondostimulants ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fécondostimulants", "description": "Quels facteurs de risque d'infertilité ?\nQuel impact des antécédents familiaux ?\nComment le poids influence-t-il la fertilité ?\nQuel rôle des maladies chroniques ?\nComment l'environnement influence-t-il la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'infertilité ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'infertilité se diagnostique par des tests hormonaux, échographies et analyses de sperme." } }, { "@type": "Question", "name": "Quels tests pour évaluer la réserve ovarienne ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par la mesure de l'hormone antimüllérienne (AMH) et l'échographie." } }, { "@type": "Question", "name": "Quand consulter un spécialiste de la fertilité ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter après un an d'essais infructueux pour les couples de moins de 35 ans." } }, { "@type": "Question", "name": "Quels signes indiquent un problème d'ovulation ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des cycles irréguliers, des règles absentes ou des douleurs pelviennes peuvent indiquer un problème." } }, { "@type": "Question", "name": "Comment évaluer la qualité du sperme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La qualité du sperme est évaluée par une analyse de sperme, mesurant la concentration et la motilité." } }, { "@type": "Question", "name": "Quels symptômes d'infertilité chez la femme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des cycles irréguliers, des douleurs pelviennes et des règles absentes." } }, { "@type": "Question", "name": "Quels signes d'infertilité chez l'homme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes peuvent inclure des problèmes d'érection, des douleurs testiculaires ou des anomalies du sperme." } }, { "@type": "Question", "name": "Comment reconnaître un déséquilibre hormonal ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'acné, la prise de poids ou des changements d'humeur peuvent indiquer un déséquilibre." } }, { "@type": "Question", "name": "Quels symptômes d'ovulation irrégulière ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des cycles menstruels irréguliers et des douleurs pelviennes peuvent signaler une ovulation irrégulière." } }, { "@type": "Question", "name": "Quels symptômes d'une maladie des ovaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs pelviennes, des règles irrégulières et des problèmes de fertilité." } }, { "@type": "Question", "name": "Comment prévenir l'infertilité ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un poids santé, éviter le tabac et gérer le stress peuvent aider à prévenir l'infertilité." } }, { "@type": "Question", "name": "Quel rôle de l'alimentation sur la fertilité ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en antioxydants et en acides gras oméga-3 peut améliorer la fertilité." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il la fertilité ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut perturber les cycles hormonaux et affecter l'ovulation, réduisant ainsi la fertilité." } }, { "@type": "Question", "name": "Pourquoi éviter les toxines environnementales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les toxines peuvent nuire à la qualité du sperme et à la santé reproductive, augmentant le risque d'infertilité." } }, { "@type": "Question", "name": "Quel impact de l'âge sur la fertilité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé réduit la qualité des ovules et la fertilité, surtout après 35 ans chez les femmes." } }, { "@type": "Question", "name": "Quels sont les principaux fécondostimulants ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux fécondostimulants incluent le clomifène, les gonadotrophines et l'acide folique." } }, { "@type": "Question", "name": "Comment fonctionne le clomifène ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le clomifène stimule l'ovulation en bloquant les récepteurs d'œstrogènes dans l'hypothalamus." } }, { "@type": "Question", "name": "Quand utiliser des gonadotrophines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les gonadotrophines sont utilisées lorsque le clomifène est inefficace ou en cas d'infertilité sévère." } }, { "@type": "Question", "name": "Quels effets secondaires des fécondostimulants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des bouffées de chaleur, des nausées et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment se déroule une stimulation ovarienne ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La stimulation ovarienne implique des injections de médicaments et un suivi échographique régulier." } }, { "@type": "Question", "name": "Quelles complications des fécondostimulants ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure le syndrome d'hyperstimulation ovarienne et des grossesses multiples." } }, { "@type": "Question", "name": "Comment reconnaître le syndrome d'hyperstimulation ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des nausées et un gain de poids rapide après traitement." } }, { "@type": "Question", "name": "Quels risques de grossesses multiples ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les fécondostimulants augmentent le risque de grossesses multiples, ce qui peut entraîner des complications." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une grossesse multiple ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples peuvent entraîner des naissances prématurées et des complications pour la mère." } }, { "@type": "Question", "name": "Quels effets à long terme des fécondostimulants ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure des risques accrus de cancer ovarien, bien que les données soient limitées." } }, { "@type": "Question", "name": "Quels facteurs de risque d'infertilité ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, des antécédents médicaux, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "Quel impact des antécédents familiaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux d'infertilité peuvent augmenter le risque d'infertilité chez les individus." } }, { "@type": "Question", "name": "Comment le poids influence-t-il la fertilité ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un poids excessif ou insuffisant peut perturber les cycles hormonaux et affecter la fertilité." } }, { "@type": "Question", "name": "Quel rôle des maladies chroniques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies comme le diabète ou le syndrome des ovaires polykystiques peuvent affecter la fertilité." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il la fertilité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des produits chimiques et à des toxines peut nuire à la qualité reproductive." } } ] } ] }

Sources (10000 au total)

Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.

To determine the risk factors for local of adult patients treated for desmoid tumors by cryoablation.... Eighty-four patients treated for nonabdominopelvic desmoid tumors by cryoablation from July 2012 to July 2020 were included in a retrospective study. The population was composed of 64 women (76.19%) a... Local relapse was found in 19 (22.62%) of 84 patients. The 12-, 24-, and 36-month progression-free survival rates were 89% (95% confidence interval [CI], 79-94), 74% (95% CI, 60-83), and 68% (95% CI, ... The local recurrence of desmoid tumors after cryoablation depends on a number of prognostic factors, in particular, a non-abdominal wall location of the tumor and previous local treatment such as surg...

Utility of vaginal vault cytology in the local recurrence of cervical cancer.

In Japan, 8000 women were newly diagnosed with cervical cancer in 2018. The healthcare insurance policy in Japan allows physicians to utilize vaginal volt cytology tests and serum biomarker measuremen... From January 2009 to December 2015, the medical records of patients with recurrence who were initially diagnosed with International Federation of Gynecology and Obstetrics stage I-III cervical cancer ... In the study period, 84 of the 981 patients experienced recurrence, and 88.1% had an asymptomatic recurrence. The disease-free interval was not related to the recurrence site. In univariate analysis, ... In this retrospective study, routine imaging analysis and serum biomarker measurement did not contribute to patient prognosis after recurrence. In contrast, vaginal vault cytology can improve survival...

Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?

Total mesorectal excision is the standard surgical procedure for rectal cancer treatment. Several studies have shown a close correlation between the prognosis of patients with rectal cancer and the co... To assess the correlation between macroscopic assessment of mesorectal excision and long-term oncological outcomes.... Retrospective analysis of an Institutional Review Board-approved database.... Tertiary referral center.... Patients with rectal cancer who were operated on between March 2016 and October 2019 were classified into 3 groups based on the mesorectal specimen quality: complete, near complete, and incomplete. On... Relationship between total mesorectal excision and local and distant recurrence rates in patients with rectal cancer.... A total of 124 patients (35.5% females) were included in the analysis, with a mean age of 58.1 (SD 12) years and a mean BMI of 26.4 (SD 4.59) kg/m². Neoadjuvant chemoradiation was administered to 71% ... Retrospective, single-center study with relatively short follow-up.... In the era of a multidisciplinary approach and extensive use of neoadjuvant therapy, macroscopic completeness of total mesorectal excision may not be as valuable a prognosticator as in the past. Large... ANTECEDENTES:La escisión total desl mesorrecto es el estándar de oro para el tratamiento del cáncer de recto. Varios estudios han demostrado una estrecha correlación entre el pronóstico de los pacient...

Symptoms and diagnosis of local recurrence after rectal cancer treatment.

The prognosis for local recurrence after rectal cancer treatment is poor. A minority of patients are eligible for surgery with curative intent, which could possibly be improved by earlier detection. T... In a population-based retrospective cohort (cohort A), all patients who had undergone resection surgery for rectal cancer in the region of Västra Götaland, Sweden, diagnosed 2010-2014, were identified... Cohort A consisted of 1208 patients, out of whom 78 (6%) were diagnosed with local recurrence. Forty-six patients were diagnosed between scheduled follow-up visits. Fifty-eight patients were symptomat... A majority of patients with local recurrence were diagnosed outside of the scheduled follow-up. Most of the patients were symptomatic at diagnosis. Symptoms were common in patients after rectal cancer...

Clinicopathological Characteristics of Anastomotic Recurrence After Curative Resection for Colorectal Cancer: Comparison With Nonanastomotic Local Recurrences.

Anastomotic recurrence is thought to be caused by implantation of tumor cells to the anastomotic line; however, its risk factors and prognostic significance remain unclear.... This study aimed to clarify the risk factors for anastomotic recurrence in colorectal cancer and assess the prognosis in comparison to nonanastomotic local recurrence.... A single-center retrospective observational study.... The medical records of the study participants were retrospectively collected from the Department of Surgical Oncology at the University of Tokyo Hospital database.... This study included 1584 patients with colorectal cancer who underwent surgical resection between January 2005 and December 2017. We focused on 15 patients who had an anastomotic recurrence.... The main outcome measures were the risk factors of anastomotic recurrence at the primary resection and prognosis data in comparison to that of nonanastomotic local recurrence.... There were 15 patients (0.95%) with anastomotic recurrence and 35 (2.21%) with nonanastomotic local recurrence. Univariate analysis revealed that lymph node metastasis and advanced T stage are the ris... The small number of patients with anastomotic recurrence is a major limitation of this study. Additionally, the retrospective study design may have increased the risk of selection bias.... Lymph node metastasis and advanced T stage were associated with anastomotic recurrence. The prognosis of patients with anastomotic recurrence was similar to that with resected nonanastomotic local rec... ANTECEDENTES:Se cree que la recurrencia anastomótica es causada por la implantación de células tumorales en la línea anastomótica; sin embargo, los factores de riesgo asociados y el significado en cua...

Value of 99m Tc-MIBI SPECT/CT in the localization of recurrent lesions in patients with suspected recurrent parathyroid carcinoma.

Accurate preoperative localization of tumor-bearing lesions is crucial for the successful surgical management of suspected recurrent parathyroid carcinoma. The purpose of this study was to evaluate th... Twenty-nine patients with suspected recurrent parathyroid carcinoma were included in this retrospective cohort study. Patients underwent preoperative 99m Tc-MIBI SPECT/CT and cervical ultrasound. The ... Of the 29 patients, histopathological results revealed 48 metastases/recurrent lesions in 26 patients. The diagnostic value of 99m Tc-MIBI SPECT/CT, cervical ultrasound, and the two modalities in comb... The combined use of 99m Tc-MIBI SPECT/CT and cervical ultrasound is the most efficient strategy in the diagnosis of parathyroid carcinoma relapse, whereas 99m Tc-MIBI SPECT/CT is the preferred method ...

Mohs microsurgery for localized penile carcinoma: 10 year retrospective review of local recurrence rates and surgical complications.

To investigate the local recurrence rates of men treated with Mohs microsurgery (MMS) for penile carcinoma. The secondary outcome was surgical complications from the MMS procedure or the subsequent re... All patients from 2010 to 2020 with penile carcinoma at our institution were seen in a multidisciplinary setting. Patients with Ta, Tis, T1, and T2 disease were considered candidates for MMS. Clinical... A total of 43 patients met inclusion criteria. The median age at diagnosis was 64 years. Stage distribution was Ta in 4.7%, Tis in 58.1%, T1a in 14.0%, T1b in 7.0%, and T2 in 16.3%. No patients had a ... MMS provides effective local control for Ta, Tis, and T1 penile cancer with an overall local recurrence rate of 2% and an acceptable complication rate. A multi-disciplinary team involving urologic onc...

Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series.

Phyllodes tumours of the breast are rare fibroepithelial neoplasms with a propensity for recurrence. While surgical excision remains the standard of care, the optimal margin width is an area of active... We conducted a retrospective, cohort study of patients with phyllodes tumours treated at our institution between 2003 and 2021. Demographic, histopathological, and recurrence data were captured; malig... Of 187 patients with phyllodes tumours, 82.9% (n = 155) were classified as benign while 17.1% (n = 32) were borderline. Initial surgical margins were positive in 26.2% (n = 49), < 2 mm in 50.8% (n = 9... In this large cohort of benign and borderline phyllodes tumours, positive resection margins and not margin width at the initial surgery were associated with a increased recurrence. Individualization o...

Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?

Patients with locally recurrent rectal cancer (LRRC) generally have poor prognosis, especially those who have (a history of) distant metastases. The aim of this study was to investigate the impact of ... Consecutive patients with surgically treated LRRC between 2005 and 2019 in two tertiary referral hospitals were retrospectively analysed. Oncological survival of patients without distant metastases we... A total of 535 LRRC patients were analysed, of whom 398 (74%) had no (history of) metastases, 22 (4%) had synchronous metastases with the primary tumour, 44 (8%) had metachronous metastases, and 71 (1... LRRC patients with synchronous distant metastases undergoing curative surgery have relatively poor prognosis. However, LRRC patients with a history of distant metastases diagnosed nearby the primary t...